The cost-effectiveness of human papillomavirus screening for cervical cancer
- 1 March 2005
- journal article
- review article
- Published by Springer Nature in The European Journal of Health Economics
- Vol. 6 (1), 30-37
- https://doi.org/10.1007/s10198-004-0254-1
Abstract
Screening strategies, Human papillomavirus testing, Cost-effectiveness ratio, Cost per quality-adjusted life-year, Life years saved,Keywords
This publication has 12 references indexed in Scilit:
- An evaluation of liquid-based cytology and human papillomavirus testing within the UK cervical cancer screening programmeBritish Journal of Cancer, 2004
- Cost-Effectiveness of Human Papillomavirus DNA Testing for Cervical Cancer Screening in Women Aged 30 Years or MoreObstetrics & Gynecology, 2004
- Economic evaluation of human papillomavirus screening in GermanyThe European Journal of Health Economics, 2003
- American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and CancerCA: A Cancer Journal for Clinicians, 2002
- Health economics and cervical cancer prevention: a global perspectiveVirus Research, 2002
- Benefits and Costs of Using HPV Testing to Screen for Cervical CancerJAMA, 2002
- Cost-effectiveness of Alternative Triage Strategies for Atypical Squamous Cells of Undetermined SignificanceJAMA, 2002
- Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 womenBritish Journal of Cancer, 2001
- Reflex human papillomavirus deoxyribonucleic acid testing in women with abnormal Papanicolaou smearsAmerican Journal of Obstetrics and Gynecology, 1998
- Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the (cost-)effectivenessBritish Journal of Cancer, 1997